West Africa: Ebola Vaccine 'Highly Effective', Results Show

[WHO] Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of international experts - the Data and Safety Monitoring Board -- that conducted the review, advised that the trial should continue. Preliminary results from analysis of these interim data are published today in the British journal The Lancet.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news